Immunology startup Infinimmune is developing antibody drugs with potential advantages over traditional monoclonal antibodies. The Series A financing will support two lead programs entering the clinic in atopic dermatitis.
The post Infinimmune Secures $75M for a More Human Approach to Developing Better Antibody Drugs appeared first on MedCity News.
Microsoft Plugs Nearly 400 Security Holes
Microsoft today released updates to remedy at least 398 security vulnerabilities in its Windows operating systems and supported software, including one weakness that is already
